Literature DB >> 3416444

Abbott's fluorescence polarization immunoassay for cyclosporine and metabolites compared with the Sandoz "Sandimmune" RIA.

A Sanghvi1, W Diven, H Seltman, T Starzl.   

Abstract

A new procedure for measuring cyclosporine in plasma has been introduced by Abbott Laboratories, involving their TDx instrumentation and fluorescence polarization immunoassay. Radioimmunoassay (RIA) and high-performance liquid chromatography are currently the conventional methods for measuring cyclosporine in plasma and whole blood. In an effort to find a method that will decrease the radioactive hazard, the reagent and supply cost, and the labor requirements associated with RIA procedures, we used specimens from transplantation patients to compare the Abbott assay with the Sandoz Sandimmune assay. We believe that the Abbott assay offers some advantages over the Sandimmune RIA procedure, providing a reliable but simpler and less hazardous technology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416444      PMCID: PMC2998386     

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Sensitivity of activated human lymphocytes to cyclosporine and its metabolites.

Authors:  A Zeevi; R Venkataramanan; G Burckart; C P Wang; N Murase; D H Van Thiel; T E Starzl; L Makowka; R J Duquesnoy
Journal:  Hum Immunol       Date:  1988-02       Impact factor: 2.850

2.  Impact of organ transplant program on the Clinical Chemistry Laboratory at the University of Pittsburgh.

Authors:  A Sanghvi
Journal:  Arch Pathol Lab Med       Date:  1986-02       Impact factor: 5.534

Review 3.  Immunoassays in therapeutic drug monitoring.

Authors:  L J Blecka; G J Jackson
Journal:  Clin Lab Med       Date:  1987-06       Impact factor: 1.935

4.  Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells.

Authors:  A Zeevi; G Eiras; G Burckart; L Makowka; R Venkataramanan; C P Wang; D H Van Thiel; N Murase; T E Starzl; R Duquesnoy
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

5.  Cyclosporin A assay: conditions for sampling and processing of blood.

Authors:  J W van den Berg; M L Verhoef; A J de Boer; S W Schalm
Journal:  Clin Chim Acta       Date:  1985-04-30       Impact factor: 3.786

6.  Fluorescence polarization immunoassay. II. Analyzer for rapid, precise measurement of fluorescence polarization with use of disposable cuvettes.

Authors:  S R Popelka; D M Miller; J T Holen; D M Kelso
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

7.  Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination.

Authors:  M E Jolley; S D Stroupe; K S Schwenzer; C J Wang; M Lu-Steffes; H D Hill; S R Popelka; J T Holen; D M Kelso
Journal:  Clin Chem       Date:  1981-09       Impact factor: 8.327

  7 in total
  2 in total

1.  A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.

Authors:  A Lindholm; R Dahlqvist; G G Groth; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

Review 2.  Therapeutic monitoring of cyclosporin--an update.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.